1. Home
  2. ASAN vs NVAX Comparison

ASAN vs NVAX Comparison

Compare ASAN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Asana Inc.

ASAN

Asana Inc.

N/A

Current Price

$9.81

Market Cap

2.1B

Sector

Technology

ML Signal

N/A

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$8.52

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASAN
NVAX
Founded
2008
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
ASAN
NVAX
Price
$9.81
$8.52
Analyst Decision
Hold
Buy
Analyst Count
15
9
Target Price
$10.23
★ $14.11
AVG Volume (30 Days)
4.5M
★ 6.1M
Earning Date
12-01-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
27.93
★ 309.76
EPS
★ N/A
N/A
Revenue
$790,806,000.00
★ $1,123,479,000.00
Revenue This Year
$8.95
N/A
Revenue Next Year
$7.86
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
9.25
★ 64.69
52 Week Low
$5.38
$6.20
52 Week High
$15.28
$13.39

Technical Indicators

Market Signals
Indicator
ASAN
NVAX
Relative Strength Index (RSI) 43.22 37.52
Support Level $9.67 $7.81
Resistance Level $10.40 $10.53
Average True Range (ATR) 0.55 0.76
MACD -0.26 -0.16
Stochastic Oscillator 17.81 5.98

Price Performance

Historical Comparison
ASAN
NVAX

About ASAN Asana Inc.

Asana Inc is the system of action for work, built for the Agentic Enterprise. It provides a comprehensive solution where humans and AI agents can collaborate effectively so that individuals work smarter, teams move faster, and organizations deliver results. Companies use Asana to connect their work to company goals and orchestrate mission-critical workflows like product launches, employee onboarding, resource planning, tracking company-wide strategic initiatives and more. It manages its operations and allocates resources as a single operating and reportable segment. The company generates revenues from subscriptions from paying customers accessing its cloud-based platform.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: